Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Efficacy and safety of adalimu...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Efficacy and safety of adalimumab in the treatment of Rheumatoid Arthritis (RA) in real-life clinical practice: 1-year-results of the react study
Bibliographic Details
Main Authors:
Burmester, G
,
Wordsworth, P
,
Saez, I
,
Malaise, MG
,
Kary, S
,
Kupper, H
Format:
Conference item
Published:
2006
Holdings
Description
Similar Items
Staff View
Similar Items
Remission and major clinical response in active rheumatoid arthritis (RA) patients after adalimumab (Humira (R)) treatment
by: Burmester, G, et al.
Published: (2007)
Efficacy and safety of adalimumab (Humira (R)) in European clinical practice: The ReAct trial
by: Burmester, G, et al.
Published: (2005)
T cell genetics and rheumatoid arthritis (RA)
by: Wordsworth, P
Published: (1998)
Adalimumab treatment with and without methotrexate in patients with moderate to severe psoriatic arthritis: Results from adept
by: Kavanaugh, A, et al.
Published: (2005)
Comparison of Efficacy and Safety of Original and Biosimilar Adalimumab in Active Rheumatoid Arthritis in a Real-World National Cohort
by: Claudiu Costinel Popescu, et al.
Published: (2022-12-01)